DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo



54.85 -1.37 (-2.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLVS $54.85 -2.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.10
Previous Close $56.22
Daily Range $53.66 - $56.56
52-Week Range $30.43 - $93.33
Market Cap $1.9B
P/E Ratio -18.59
Dividend (Yield) $0.00 (0.0%)
Volume 514,859
Average Daily Volume 634,034
Current FY EPS -$4.09




Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website:

News & Commentary

The Past, Present, and Future of Lung Cancer Treatments

Although smoking rates in the U.S. have steadily declined over the past five decades, lung cancer remains one of the deadliest cancers among Americans. Will current and future treatments from Roche, Pfizer, Clovis, and Inovio save more lives over the next few years?

3 Biotech Stocks Trading The Wrong Direction In March

Benzinga's Volume Movers

4 Stocks Triggering Breakouts on Big Volume

Sector Update: Healthcare Shares Flat Pre-Market; Baxter up 12% on Plans to Split Into 2 Companies

Sector Update: Healthcare

Benzinga's Top #PreMarket Gainers

Benzinga's Top Initiations

Top Analyst Upgrades and Downgrades: BofA, NetApp, Stratasys, Symantec, Wells Fargo and More

Clovis Oncology Larger Than S&P 500 Component Cliffs Natural Resources

'Fast Money' Recap: China Syndrome

See More CLVS News...